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a b s t r a c t
This article applied the Black-Scholes option valuation formula to calculating high-cost illness reinsurance premiums in the Colombian 
health system. The coverage pattern used in reinsuring high-cost illnesses was replicated by means of a European call option contract. 
The option’s relevant variables and parameters were adapted to an insurance market context. The premium estimated by the Black-
Scholes method fell within the range of premiums estimated by the actuarial method.
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El artículo hace una aplicación del  método de valoración de opciones de Black-Scholes al cálculo de primas de reaseguro de enferme-
dades de alto costo en el sistema de salud de Colombia.  Se replicó el patrón de cobertura utilizado en el reaseguro de enfermedades 
de alto costo por medio del contrato de una opción call tipo europeo.  Las variables y parámetros relevantes de la opción fueron adapta-
dos al contexto del mercado de seguros. La prima estimada por medio de la metodología de Black-Scholes se ubicó dentro del rango 
estimado por medio del método actuarial. 
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The Colombian health system is comprised of Insur-
ing Firms and Providing Firms. Insuring Firms (called 
Health Promotion Entities or Entidad Promotora de 
Salud, EPS, in Spanish) take care of its affiliates, the 
financial resources, organising the service and provid-
ing affiliates with risk management and high-cost ill-
ness reinsurance. Providing Firms are hospitals, clinics 
and physicians that actually deliver the health care it-
self.
This system simulates a competitive market by fixing 
a price known as “per capita payment unit” (PCPU) 
and by establishing a product named the Compulsory 
Health Plan (CHP). The PCPU is the value that the 
system gives to EPS per affiliate, according to age, 
gender and geographic location. The CHP is a com-
prehensive health protection plan covering maternity 
and general illness in the phases of health promotion 
and advancement, prevention, diagnosis and treat-
ment of various 1st, 2nd, 3rd and 4th level activities 
and procedures. With the value of the PCPU per af-
filiate, insuring firms must guarantee CHP provision 
(Chicaíza, 2002).
One of the main risks facing insuring firms arises when 
the cost per insured individual becomes excessive. Re-
insurance is the mechanism used by the system to pro-
tect EPS against the risk of covering affiliates with 
high-cost diseases. It is mandatory for insuring firms to 
reinsure high-cost illnesses. What is legally defined as 
high cost represents the minimum that must be rein-
sured.  There are two available reinsurance methods:
Reinsurance contracts can be established to cover • 
the excess costs caused by the unexpected occur-
rence of a specific pathology; or alternatively,
They can be established to cover any event exceed-• 
ing a specific amount per patient (financial alter-
native). 
Both ways of reinsuring high-cost diseases are found 
in the Colombian Health Care System. However, most 
EPS prefer the second possibility, since, it avoids dis-
cussion about controversial medical questions, and 
therefore facilitates the recovery of costs from the re-
insurance firm1. 
1   There are differences in the criteria about what a treatment 
precisely includes, ambiguity about the scope of the coverage 
due to the difficulty of assessing whether a certain event has 
gone beyond the expected frequency (as it is this excess that is 
to be reinsured), and so on. Moreover, legal definitions of high 
cost in health care may include pathologies, syndromes, pro-
cedures, surgical operations, services, events and treatments, 
all of which complicates negotiations between agents over re-
insurance contracts and the costs of their claims.
We focus our empirical work on this financial alterna-
tive because its coverage pattern can be replicated by 
using option contracts (Chicaíza and Cabedo, 2007). 
We use this equivalence to calculate an insurance pre-
mium valuation framework by using option pricing 
theory.  Although the equivalence is well known in 
the theoretical literature, this is the first time that it 
has been applied to an actual case.
Insurance premiums have been traditionally estab-
lished by means of actuarial methodologies. The meth-
od used here provides an alternative to the traditional 
ones.
The rest of the paper is structured as follows: in the 
next section we describe shortly the use of derivatives 
in risk hedging.  In section 3 we propose a method 
to replicate the hedging pattern of a high-cost illness 
insurance operation by using option contracts. This 
section also demonstrates that, in an equilibrium situ-
ation, the premium paid for the coverage pattern when 
using option contracts must be equal to the premium 
paid when using insurance contracts. In Section 4 we 
apply the proposed method to value the premium to 
be paid to the reinsurer in one of the biggest Colom-
bian EPS. We also compare the results thus obtained 
with those provided by actuarial methods, and in the 
final section, we summarise the main conclusions of 
the paper.
2.  Derivatives in risk hedging
Many papers that have been published in recent fi-
nancial literature  show how derivatives in general 
and options in particular have been used for several 
kinds of risk hedging. For instance, in electricity mar-
kets with uncertainty surrounding spot prices and de-
mand, Bessembinder and Lemmon (2002) developed 
an equilibrium model that links forward prices with 
future spot prices for different levels of expected de-
mand and demand risk. Zettl (2002) studied the risks 
derived from alterations in oil prices and other inputs, 
and applied the option value theory to the valuation 
of exploration and production projects in the oil indus-
try, using the discrete binomial model combined with 
Monte Carlo simulations. Yangxiang Gu (2002) used 
American-style call options for hedging against risks 
in real estate prices and proposed that this kind of op-
tions be used for employee compensation contracts in 
the USA.
Karpinski (1998) points out that as options were used 
for other markets (such as electricity or impressionist 
paintings); future and simple options were replaced by 
exotic and more complex options. Although returns 
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quantifying derivatives risk has become clear. In ad-
dition to this risk, speculation by unsupervised traders 
can also bring about financial disasters. The main al-
ternative in confronting this problem has been to seek 
direct protection against this risk. On the one hand, 
according to Bhansali (1999), the introduction of cred-
it derivatives and spread options provides protection 
against credit default risk without introducing any new 
risk. On the other hand, however, other mechanisms 
that have been designed, such as variance or volatility 
swaps (Demeterfi et al., 1999),  refer to a future level of 
volatility. Although these swaps are forward or future 
contracts on volatility, they can be replicated theoreti-
cally by a covered portfolio of appropriately selected 
standard options. In this way, Das et al. (2001) stud-
ied the impact of insolvency probability correlations 
on credit. Duffe and Zhou (2001) analysed the impact 
of introducing credit derivatives in banks.
Options have also been used in transactions involving 
several countries, as in the case of currency options 
(Geczy et al., 1997), although some authors argue that 
this has increased world financial instability as there 
is a lag in the creation of institutions to regulate these 
transactions (McClintock, 1996). 
But perhaps the use of derivatives as hedging tools is 
most striking in a field where risks have traditional-
ly been managed by other instruments: the insurance 
operations field. At this point, the contributions on 
risks associated with natural catastrophes should be 
pointed out, such as those by Harrington (1997) and 
Niehaus (2002). The use of options and derivatives has 
allowed the costs involved in risk coverage to be re-
duced (Harrington, 1997) although it also seems to 
have introduced new risks. Niehaus (2002) points out 
that potential loss due to catastrophic risk has led fi-
nancial researchers to ask the following questions: to 
what extent is catastrophic risk being shared? Is its 
distribution consistent with the notion of optimal risk 
ensuring? If the distribution is not optimal, what are 
the market imperfections leading to efficient distribu-
tion of catastrophic risk? Are there government poli-
cies or private market solutions that lead to a more 
efficient outcome?
The use of derivatives in this field has transcended 
the academic discussion and has been consolidated 
through the creation of specific trading markets. For 
example, in 1992, the CBOT launched the first cover-
age tool for the insurance industry: future and option 
contracts on catastrophic risks. The underlying asset 
for these products is an accident rate index for cata-
strophic risks. This index is built from data reported by 
US firms on premiums paid and insured values. Data 
availability has contributed to the proliferation of em-
pirical studies on financial markets (Pouget, 2001). 
The success of these trading markets probably lies in 
the fact that the coverage framework provided by de-



















3. Equivalence between option contracts and 
insurance contracts
One of the lines of research referred to in the preced-
ing section is the relation between option contracts 
and insurance operations. We mentioned certain pa-
pers that deal with options on risks related to natural 
catastrophes. In this field coverage has traditionally 
been achieved by using insurance contracts. However, 
the option markets created in the nineties constitute 
an alternative to the traditional coverage method. The 
reason is probably very simple: option contracts and 
insurance and reinsurance operations are conceptu-
ally very close to each other:
Both are hedging operations: options cover agents • 
against unexpected changes in prices, while insur-
ance covers agents against unexpected contingen-
cies (accidents, illness, etc.). 
A premium must be paid: for both option and insur-• 
ance contracts a premium must be paid. The buyer 
(options) / insured (insurance) must pay a premium 
to the writer (options) / insurer (insurance) in order 
to obtain the desired hedge.
Compensation: when an unexpected situation aris-• 
es, compensation must be paid. If, for example, an 
accident occurs, the insured will receive compen-
sation. If an unexpected change in prices occurs, 
the buyer will execute the option and receive an 
amount (compensation) equivalent to the differ-
ence between the strike price and the market price. 
In any case, if the unexpected situation does not 
arise, both the insured and the buyer lose the pre-
mium paid.
Hedge period: timing of both insurance and option • 
operations is relatively short. Despite the fact that 
the time horizon of insurance cover can be set in 
years, it is always possible to unilaterally withdraw 
from the contract; the insurance company may 
purposely increase the premium, or demand condi-
tions that the agent objectively is not able to fulfil. 
Alternatively, the agent may decide to stop paying 
the premium and thus withdraw or end the insur-
ance contract. Similarly, options contracts may be 
established for short or long periods, but options 
are seldom contracted in current financial markets 
for periods longer than a year.
In the light of the above points, if we replicate an in-
surance operation using option contracts and we dem-
onstrate that the premiums to be paid are equal for 
both transactions, we can use the option pricing theo-
ry to calculate the amount of the premium to be paid 
for the coverage. 
3.1 Replicating the coverage pattern by using option 
contracts
Let us now assume that a hypothetical individual is 
considering taking out a reinsurance contract on high-
cost illnesses under the terms we have outlined above 
(financial alternative). We assume that the patient’s 
disease will generate payments three times a year: at 
moments 1, 2 and 3, and that the accumulated pay-
ments exceed the deductible. Figure 1 represents this 
situation. On the left side of the figure we show the 
payments the individual must pay out when the insur-
ance operation has not been agreed. On the right side 
we show the payments when the high-cost disease has 
been underwritten. 
As can be seen, when the risk is insured there is a 
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the total cost paid out by the individual will equal the 
deductible plus the cost of the premium paid to the 
insurer at the beginning of the year. If the risk has 
not been insured, the individual must assume the total 
cost of the treatment, which, in the situation repre-
sented in Figure 1, is higher than the cost when he or 
she is insured.
We now show how this coverage pattern can be repli-
cated by an option purchase. In this case, the buyer of 
a European-style call guarantees a maximum price for 
buying the underlying asset at the expiration date: if 
the market price of the underlying asset is lower than 
the option strike price, the holder will not exercise the 
right. If he or she wants to buy the underlying asset, 
the market price must be paid. Furthermore, the cost 
of the asset bought will be the sum of its market price 
plus the premium paid when buying the option. On 
the other hand, if the market price is higher than the 
strike price, the holder will exercise the right and will 
pay the writer the strike price for the underlying asset. 
The total cost paid by the holder will be amount to 
the sum of the strike price and the premium. Figure 2 
shows the cost of the underlying asset for a European-
style option buyer at the expiration date, depending on 
the market price.
The two hedge schemes (figures 2 and 3) are similar: 
they guarantee a maximum cost to be paid when an 
exceptional situation occurs, and for this to be pos-
sible, the insured / buyer must pay a premium. Hence, 
the question raised is whether an insurance operation 
can be defined in terms of options contracts. 
The essential elements of an option contract are the 
buyer, the writer, the expiration date, the strike price, 
the premium and the underlying asset. Let us identify 
these elements when an individual is insuring against 
high-cost diseases. Some of these elements can be eas-
ily defined: the buyer and the writer will be the indi-
vidual and the insurance company, respectively, and 
the strike price will be the deductible. But the key item 
is the underlying asset.
We define the underlying asset as the accumulated cost 
of treatment. If we define an expiration date as the end 
of the year (it must be borne in mind that annual cov-
ers are negotiated), and the premium of the option as 
the amount to be paid to the insurance company, we 
have all the items we need for an option contract.
We can replicate the coverage pattern of an insurance 
operation as follows:
The individual buys a European-style call option at • 
the beginning of the year. The insurance company 
is the writer of this call option.
The expiration date of the option is at the end of • 
the year.
The underlying asset is the accumulated cost of the • 
treatment throughout the year, and the strike price 
for the call is the deductible. 
At the expiration date, the contract will be settled • 
by differences.
Within this pattern, if the accumulated treatment 
costs at the end of the year (expiration date) are lower 
than the deductible, the individual will not have ex-
ercised his or her right and will have assumed all the 
payments. The patient’s total cost will be the accumu-
lated treatment cost plus the premium paid at the be-
ginning of the year.
In contrast, if the accumulated costs are higher than 
the deductible, the individual will exercise this option. 
The individual has the right to “buy” accumulated 
treatment costs at a price equal to the deductible. As 
the market price (the actual accumulated cost) is high-
FIGURE 2. Cost for the buyer of a European call at the expiration 
date
S: strike price; P
c
: premium
FIGURE 3. Cost of a European call 
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er than the deductible, the individual will exercise his 
or her right and “will buy” accumulated treatment cost 
at the strike price (the deductible). Or, what amounts 
to the same thing, the insurer will pay the individual 
the difference between the current accumulated costs 
(market price) and the deductible2 (strike price). In 
this way the individual will only assume the part of 
the treatment costs that falls below the deductible. 
The total cost will be the deductible plus the premium 
paid by the option. This coverage pattern is shown in 
Figure 3.
As can be seen, Figures 2 and 3 are essentially equiva-
lent. This means that an individual can achieve the 
same coverage pattern by signing a reinsurance con-
tract or, alternatively, by buying a call style option.
3.2 Premium equivalence
As shown above, we can replicate a reinsurance cover-
age pattern by using option contracts. In this section 
we will demonstrate that the premiums to be paid in 
both situations must be equivalent. With this aim we 
test the following hypothesis:
In an equilibrium situation, the premium to be paid 
for the insurance contract must equal the premium to 
be paid for the purchase of the call style option.  To 
test this hypothesis, let us assume a time when the 
price to insure against a high cost disease equals P 
monetary units (m.u.), whilst the price of buying an 
option such as those described above equals Pc m.u. 
Let us assume that:
P > Pc
An arbitrager would operate by working as an insur-
ance company and entering into an agreement with 
an individual to insure the high-cost disease. The ar-
bitrager would receive P m.u. for this. 
At the same time the arbitrager would buy a call for P
c
 
m.u. The profit obtained is the following:
Profit = P – Pc > 0
The difference is positive but, what is more important, 
this profit is achieved without assuming any risk. If, 
at the expiration date, the accumulated cost does not 
reach the deductible, the arbitrager would not exercise 
the call style option, nor would he or she have any ob-
ligation with the insured individual. But if the accu-
mulated cost at the end of the year is higher than the 
deductible, the arbitrager would pay the individual the 
difference between this cost and the deductible. How-
ever, this amount to be paid would be equivalent to 
2 The contract is settled by differences.
that received from the option writer when exercising 
the call style option bought.
This “profit without risk” opportunity would be per-
ceived immediately by the arbitragers in the market, 
who would begin to buy calls and to sell insurance 
contracts. This would produce an increase in the pre-
miums to be paid by calls and a decrease in the pre-
miums to be paid when entering into an insurance 
contract. These movements would continue until the 
equilibrium situation is restored.
A symmetric argument can be put forward for the op-
posite situation when:
P < Pc
In conclusion, in an equilibrium situation premiums 
must be equivalent. Therefore, we can use the option 
valuation theory to value the premium of an insurance 
contract.
3.3 The introduction of the top boundary
The situation described up to now does not always 
correspond to the insurance of a high-cost disease. 
We have only considered the deductible boundary, 
but, sometimes there is a second boundary: the top 
boundary. When considering the two boundaries, the 
coverage pattern provided by the insurance operation 
can be represented as shown in Figure 4.
In this figure we show the four possible situations for 
the individual:
There is no treatment and therefore no cost. In any 1. 
case, the individual must pay the premium.
The cost of the treatment falls below the amount 2. 
of the deductible. Here, payments assumed by the 
individual will be equal to the sum of the cost and 
the premium paid by the insurance operation.
The cost of the treatment falls between the amounts 3. 
established as the deductible and the top. The indi-
vidual must pay a fixed amount: the deductible plus 
the premium paid to the insurer.
The cost of the treatment falls above the amount 4. 
established as the top. In this situation the individ-
ual will pay the deductible, plus the premium, plus 
the difference between the accumulated cost at the 
end of the year and the top.
We can also replicate this coverage pattern by using 
option contracts. To do so, we construct an exotic op-
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The first option is that described up to this point • 
and is bought by the individual from the insurer. 
For this option the individual will pay a premium: 
Pc.
The second option is another European-style call • 
on the same underlying asset and with the same ex-
piration date. The strike price of this option is the 
top, and now it is the individual who sells and the 
insurer who buys the derivative asset. For this op-
tion the individual will receive a premium: Pc1.
Considering the call-put parity, the following relation 
will occur:
Pc > Pc1
And, therefore, the net premium to be paid by the in-
dividual (NP) will be:
NP = Pc – Pc1
Let us see how the coverage works with these op-
tions:
If the accumulated cost at the end of the year is • 
lower than the deductible, none of the options will 
be exercised. The cost for the individual will be de-
termined by the cost of the treatment plus the net 
premium (NP) paid.
If this accumulated cost is above the deductible but • 
below the top, only the first of the options will be 
exercised. The cost to be paid by the individual will 
be the deductible plus the net premium.
Finally, if the cost of the treatment (• C) is higher 
than the top (T), 
C > T
Both options will be exercised. By exercising the first 
call the insurer will reimburse the individual the dif-
ference between the cost of the treatment and the de-
ductible (D):
IIND = C – D
where I
IND
 denotes the incomes for the individual.
But the insurer will also exercise the call he or she has 
bought. By settling this call by differences, the indi-
vidual will pay the insurer the difference between the 
cost of the treatment (C) and the top (T):
IIND = –(C – T)
In summary, the individual will pay the cost of the 
treatment, the net premium and the difference be-
tween the cost and the top, and will receive the dif-
ference between the cost of the treatment and the 
deductible. The net exit of funds for the individual will 
be determined by:
EIND = C + NP + (C – T) – (C – D) =
= C + NP + D – T
where E
IND
 denotes the cost to be paid by the indi-
vidual.
The coverage pattern provided by simultaneously us-
ing two calls is the same of figure 4 in an equilibrium 
situation.
To summarise, we have demonstrated that we can 
replicate the coverage pattern provided by a reinsur-
ance operation using an exotic option, constructed by 
combining two option contracts. Moreover, we have 
shown that the premiums to be paid by options and by 
the reinsurance coverage must be equal. Therefore, we 
can use option pricing theory to estimate the amount 
of the premium to be paid by a reinsurance operation.
FIGURE 4. Coverage pattern including the top and the deductible 
D: deductible; T: Top; P: premium
4. Data and valuation model
For the empirical application of the proposed valua-
tion method, we used the medical bills of an EPS3 that 
has been operating in the Colombian Health Care 
System since January 1999.4 All figures are expressed 
in Colombian 2002 pesos5.  We selected the bills cor-
responding to the period between October 1999 and 
September 2002 (over 600,000). In this three-year pe-
riod, the EPS signed three reinsurance contracts for 
high-cost diseases. The relevant details of these con-
tracts are shown in Figure 5.
As seen, for example, for the period between October 
2001 and September 2002, the EPS entered into an in-
surance contract with a deductible of $50.000.000 for 
3 The EPS preferred to remain anonymous.
4 Records prior to this date were not considered reliable.
5 The average exchange rate for that year was $2.507.
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which it had to pay a monthly premium per affiliate of 
between $202 and $417.  
We divided the analysis period into two sub-periods:
October 1999 – September 2001: data from this pe-• 
riod was used for calculation purposes.
October 2001 – September 2002: data from this pe-• 
riod was used for validation purposes.
Within the calculation period, we estimated the cost 
accumulated over 12 months at September 2000 and 
at September 2001 for each affiliate. Most of the accu-
mulated accounts were very small. Therefore, we chose 
for working purposes only those above $8.000.0006. 
Thus, we finally worked with 700 affiliates for the pe-
riod ending September 2000, and with 1,200 affiliates 
for the period ending September 2001.
For the valuation of the premium, we used the Black-
Scholes (1973) model7. The variables needed to apply 
the model are as follows:
S:  the price of the underlying asset. This is defined 
individually for each EPS affiliate.
E:  the strike price, equal to the deductible agreed with 
the reinsurer.
r:  the continuous time interest rate. This is the rate 
standing at the time the option is valued.
t:  time to maturity. One year. The reinsurance is un-
derwritten annually and the right to compensation 
can only be exercised at the end of that period.
σ:  volatility of the yield (price variation) of the under-
lying asset. 
Once the values of these variables are known, the pre-
mium can be calculated directly with the well-known 





6 For this value, considering the level for the deductible (strike 
price), the premium would be about 0.
7  This is a suitable model for valuing European-style options 
like the one we price in this paper. Nevertheless, other val-

































where the underlying asset does not generate any re-
turn.
In addition, the following hypotheses were assumed 
when applying the model:
The underlying asset follows a continuous Gauss • 
Wiener stochastic process.
Volatility is the same for all the affiliates’ ac-• 
counts.8
Coverage is reached by buying a call for each EPS • 
affiliate, and those whose annual hedging premium 
is less than $1 are neglected.
The accumulated bill at the moment of calculat-• 
ing the premium is below the normal situation to 
be expected at the end of any annual period. More 
precisely, the mean values and the distribution of 
the accumulated values are assumed to be constant 
between consecutive periods.9
4.1 Volatility estimation
The key variable when valuing these premiums is the 
volatility of the yield of the underlying asset. As it is 
not an observable variable, a hypothesis must be as-
sumed in order to estimate volatility from the infor-
mation available at the moment of the valuation. To 
achieve this aim, first we constructed a time series for 
the yield of the underlying asset and then estimated 
the volatility from this time series.
To construct the time series, we calculated the daily 
mean value of the medical bills recorded by the EPS 
8   This is only a simplifying hypothesis. It is not essential for the 
method we propose.
9  Some tests on this hypothesis are calculated below.
FIGURE 5. Reinsurance premiums and coverage contracted by the EPS (Colombian pesos)
Period Deductible Top Coverage Monthly premium per affiliate
Oct/1999 – Sept/00 $8 000 000 $50 000 000 High cost pathologies $940 - $1.453
Oct/00 – Sept/01 $50 000 000 $450 000 000 Any kind of pathologies $243 - $739
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for all the days in the calculation period (October 
1999 – September 2001). From this information, for 
the first day of 2000, we calculated the accumulated 
value of the mean medical bill over the previous 12 
months. We repeated this operation for every day be-
tween October 2000 and September 2001. In this way 
we obtained a daily series of accumulated recorded 
bills over one year. 
The next step was to estimate the daily variation of 
these accumulated values in relative terms. We used 
the logarithmic approximation and obtained a one-
year time series of daily returns of the underlying as-
set. This series is shown in Figure 6.
At this point we need to forecast the value of the vola-
tility for the valuation period (October 2000-Septem-
ber 2002) in order to estimate the option premium. 
With a reduced number of observations, as in this 
case, perhaps the most suitable alternative is the sim-
plest one: to consider the volatility of the last time pe-
riod as the best forecast for the next period. However, 
before assuming this behaviour, we tested the possibil-
ity of an autoregressive conditionally heteroscedastic 
(ARCH) pattern.
We studied both the autocorrelation and partial au-
tocorrelation functions. They do not suggest the exis-
tence of an autoregressive or moving average pattern 
for the daily variation of accumulated medical bills. 
This was further confirmed by the Ljung-Box test, 
the results of which do not allow us to reject the null 
hypothesis that the variable has no statistically sig-
nificant autocorrelation (see Figure 7). Once autocor-
relation in the series had been ruled out, we tested the 
existence of autocorrelation when we square the vari-
able. Again, as shown in Figure 7, the Ljung-Box test 
rejects the tested null hypothesis, and this indicates 
that an ARCH pattern is not probable. Moreover, in 
searching for this pattern, we estimated the Lagrange 
multiplier test proposed by Engle (1982). The results, 
shown in Figure 7, definitively reject an autoregressive 
conditionally heteroscedastic pattern.
FIGURE 6. Daily return of accumulated value of bills October 2000 - September 2001 
FIGURE 7. Ljung Box Test and Lagrange multiplier test
Ljung-Box Q-Statistics (original series) Ljung-Box Q-Statistics (squared values)
Q(12)  =  1.5152.  Significance Level  0.99986218 Q(12)  =  0.1054.  Significance Level 1.00000000
Q(24)  =  2.8926.  Significance Level  0.99999995 Q(24)  =  0.2254.  Significance Level 1.00000000
Q(36)  =  4.7100.  Significance Level  1.00000000 Q(36)  =  0.3301.  Significance Level 1.00000000
Chi-squared=   0.012392 Significance level 0.99382316
 

































Once we have rejected using an ARCH pattern, a 
possible alternative is to use the realised volatility as 
a forecast for future values. Hence we estimated the 
standard deviation for the daily return of accumulated 
medical bills during the period October 2000 – Sep-
tember 2001. The standard deviation on a daily basis 
equals 0.0155. However, the relevant value for the de-
viation is that expressed in annual terms. Multiplying 
0.0155 by the square root of the number of days on 
which bills were recorded gives us a result of 0.239. 
This is the value corresponding to the standard devia-
tion for the period October 2000 – September 2001, 
on an annual basis. We use this value as a forecast for 
the volatility in the validation period, that is, October 
2001 – September 2002.
4.2 The estimation of the premium
After determining the volatility, the other parameters 
of the model must be specifically defined in order to 
calculate the premium. At this point, the market price 
of the underlying asset becomes especially important. 
As we have stated above, we define the underlying 
asset as the accumulated cost over the previous 12 
months. If we estimate a premium for each of the affil-
iates, there will be as many different prices as there are 
EPS affiliates. We know the number of affiliates at the 
moment we value the premium, but not the number 
of affiliates for the following year. For this reason we 
assumed one of the aforementioned hypotheses: the 
distribution of accumulated bills does not change be-
tween consecutive periods.
To test this hypothesis at the moment we value the 
premiums (October 2001), we compare the statisti-
cal distribution of the accumulated costs for the two 
consecutive annual periods where data are available: 
October 1999 – September 2000 and October 2000 – 
September 2001. Both distributions are represented in 
the box graph shown in Figure 8.




















As can be seen, there is a high degree of coincidence 
between the two boxes, which suggests that there are no 
significant differences between the averages of the two 
periods. This is supported by the Kolmogorov-Smirnov 
test, where the null hypothesis is the equality between 
the distribution functions for both periods against the 
alternative hypothesis that assumes that the statisti-
cal distribution for the period between October 1999 
and September 2000 is different from that for the pe-
riod October 2000 – September 2001. The value for 
the Kolmogorov-Smirnov statistic is 0.064, while the 
critical value for a 99% confidence level is 0.068. This 
allows us to conclude, with a level of confidence of 
99% that the null hypothesis cannot be rejected and 
we accept that both time periods have the same sta-
tistical distribution. In other words, the statistical dis-
tribution for the variable studied (the daily return of 
the accumulated cost) has not changed between two 
consecutive time periods. We assume this behaviour 
for the future and therefore we do not expect changes 
in the statistical distribution between the period Oc-
tober 2000 – September 2001 and the period October 
2001 – September 2002 (the latter being the valida-
tion period).
With this assumption we estimate the premium for 
each of the affiliates, considering its accumulated cost 
at September 2001. For example, for the affiliate with 
the highest accumulated cost ($129.184.208) the pre-
mium is $84.660.626. We repeated this calculation for 
each of the 1,200 affiliates considered in September 
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The value estimated by means of the option-pricing 
theory therefore lies inside the range negotiated with 
the reinsurer, which was estimated using actuarial 
techniques.
Nevertheless, the estimation made to present has not 
taken into account the existence of a $450.000.000 
top, above which the EPS pays the excess. This vari-
able is easily introduced into the model. As stated 
above, this involves the simple design of an exotic op-
tion contract that replicates this situation. This would 
be equivalent to assuming that, when the described 
call style option (strike price: $50.000.000, one year 
period, etc.) is bought from the reinsurer, a call is si-
multaneously sold to the reinsurer with the same fea-
tures, but at a strike price of $450.000.000. 
When both options are negotiated, the coverage situa-
tion can be described as follows (see also Figure 4):
If the price of the underlying asset lies below • 
$50.000.000, the buyer of the call (the EPS) does 
not exercise its right, but nevertheless pays the total 
accumulated value of the bill (plus the net premi-
um, NP). The buyer of the call with a strike price of 
$450.000.000 would not exercise its right either.
If the underlying price lies between $50.000.000 • 
and $450.000.000, the reinsurer will not exercise 
the call it bought, but the EPS will exercise its op-
tion and pay the maximum value of $50.000.000 
(plus the net premium). 
Finally, if the underlying price lies above • 
$450.000.000, both parties will exercise their op-
tions; the reinsurer (as seller of a call with a strike 
price of $50.000.000) will pay the EPS the differ-
ence between the price of the underlying asset (C) 
and this strike price. But the EPS must also pay the 
reinsurer the difference between the price of the 
underlying asset and the strike price of the second 
of the options ($450.000.000). In accordance with 
(9), the net payment of the EPS would be the de-
ductible plus the excess of the cost of the treatment 
on the top plus the net premium:
C + NP+50.000.000 - 450.000.000 = 
= 50.000.000 + (C - 450.000.000) + NP =
= C+NP-400.000.000
For the EPS, selling a call option represents an income 
or a lower premium to be paid to the reinsurer for the 
coverage. Therefore, with regard to the call options 
bought by the EPS, we calculated the amount corre-
sponding to the premiums of the calls sold by this firm. 
The data used are the same, with the exception of the 
strike price, which is now $450.000.000. As the top 
market price of the underlying asset (the individual ac-
cumulated cost).
4.3 Comparative analysis between the option 
premium and the one calculated by actuarial 
methods
The sum of all premiums for all affiliates with ac-
cumulated bills higher than $14.202.442 equals 
$2.078.754.97010 and the number of affiliates at the 
time of valuation was 620,193. Hence, the premium 
per affiliate would be $3.351,79 for a whole year’s cov-
erage. However, this premium is not paid immediately 
at the beginning of the coverage period, but rather is 
deferred 12 months and paid in instalments at the be-
ginning of each month. Thus, the former individual 
figure must be transformed into a 12-month constant 
pre-payable rent with an interest rate11 of 0.01025, the 
current value of which is $3.351,79; the result means 
that the EPS should pay a monthly premium per af-
filiate of $295,25 . At present, the EPS that provid-
ed data for this study has underwritten a contract 
with the reinsurer in which the monthly premium lies 
within the range between $202 and $417 per affiliate 
(see Figure 5).
10 Lower values provide premiums below $1.
11 The nominal Colombian market interest rate, (12.3%) divid-
ed by 12.
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was set at such a high level, with respect to the nor-
mal accumulated annual bill, almost all the premiums 
are lower than $1. We only obtain premiums above $1 
for values of the underlying asset above $115.000.000, 
although the amount is still insignificant. As a con-
sequence, the existence of this top boundary has no 
significant impact on the valuation of the premiums to 
be paid by the EPS.
5. Conclusions
The calculations made show that the Black-Scholes 
model, used to value options, may also be used to es-
timate reinsurance premiums of high cost-illness. The 
premium estimated by this method is not far from the 
premiums estimated by the actuarial method.
To sum up, as options provide a similar scheme of 
protection to that of insurance, given that they are 
both financial tools allowing coverage of certain risks 
in exchange of a premium, it is reasonable to use op-
tion valuation theory in valuing insurance premiums 
in general and high-cost diseases reinsurance in par-
ticular. 
In any case, beyond the particular application we have 
carried out in this paper, the proposed premium valua-
tion method can be extended to other firms and other 
insuring situations: the variables we have defined can 
be easily adapted to other situations, and most of the 
hypotheses we have assumed (e.g. those relative to a 
unique volatility for all the affiliates) can be substi-
tuted by others relevant to each particular situation 
with no modification to the valuation procedure. It al-
lows the valuation of premiums by using an alternative 
instrument to the one used by insurance firms, which 
would help increase competition in negotiations with 
the Colombian reinsurance market.
In any case, any adaptation to the model requires the 
availability of enough information. Lack of informa-
tion is perhaps the main limitation to be found now in 
applying it to other firms.
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